Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 214

Related Citations for PubMed (Select 20331759)

1.

Correlation of transient elastography with APRI and FIB-4 in a cohort of patients with congenital bleeding disorders and HCV or HIV/HCV coinfection.

Vidovic N, Lochowsky RS, Goldmann G, Rockstroh J, Wasmuth JC, Spengler U, Sauerbruch T, Lammert F, Oldenburg J, Grünhage F.

Haemophilia. 2010 Sep 1;16(5):778-85. doi: 10.1111/j.1365-2516.2010.02204.x. Epub 2010 Mar 15.

PMID:
20331759
2.

Comparison of transient elastography (FibroScan), FibroTest, APRI and two algorithms combining these non-invasive tests for liver fibrosis staging in HIV/HCV coinfected patients: ANRS CO13 HEPAVIH and FIBROSTIC collaboration.

Castera L, Winnock M, Pambrun E, Paradis V, Perez P, Loko MA, Asselineau J, Dabis F, Degos F, Salmon D.

HIV Med. 2014 Jan;15(1):30-9. doi: 10.1111/hiv.12082. Epub 2013 Sep 6.

PMID:
24007567
3.

Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.

Mendeni M, Focà E, Gotti D, Ladisa N, Angarano G, Albini L, Castelnuovo F, Carosi G, Quiros-Roldan E, Torti C.

Clin Infect Dis. 2011 May;52(9):1164-73. doi: 10.1093/cid/cir071.

4.

Evaluating liver fibrosis progression and the impact of antiretroviral therapy in HIV and hepatitis C coinfection using a noninvasive marker.

Al-Mohri H, Murphy T, Lu Y, Lalonde RG, Klein MB.

J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):463-9.

PMID:
17211282
5.

Comparison of FIB-4 and APRI in HIV-HCV coinfected patients with normal and elevated ALT.

Shah AG, Smith PG, Sterling RK.

Dig Dis Sci. 2011 Oct;56(10):3038-44. doi: 10.1007/s10620-011-1710-2. Epub 2011 Apr 28.

PMID:
21526398
6.

Use of simple noninvasive biomarkers to predict liver fibrosis in HIV/HCV coinfection in routine clinical practice.

Macías J, González J, Ortega E, Tural C, Cabrero E, Burgos A, Pineda JA; GRAFIHCO Study Team.

HIV Med. 2010 Aug;11(7):439-47. doi: 10.1111/j.1468-1293.2009.00812.x. Epub 2010 Feb 17.

PMID:
20180868
7.

Transient elastography: a non-invasive tool for assessing liver fibrosis in HIV/HCV patients.

Li Vecchi V, Soresi M, Colomba C, Mazzola G, Colletti P, Mineo M, Di Carlo P, La Spada E, Vizzini G, Montalto G.

World J Gastroenterol. 2010 Nov 7;16(41):5225-32.

8.

Prospective noninvasive analysis of hepatic fibrosis in patients with Crohn's disease: correlation of transient elastography and laboratory-based markers.

Brühl J, Schirren M, Wei C, Antoni C, Böcker U.

Eur J Gastroenterol Hepatol. 2011 Oct;23(10):923-30. doi: 10.1097/MEG.0b013e3283499252.

PMID:
21814142
9.

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers.

Vermehren J, Vermehren A, Mueller A, Carlebach A, Lutz T, Gute P, Knecht G, Sarrazin C, Friedrich-Rust M, Forestier N, Poynard T, Zeuzem S, Herrmann E, Hofmann WP.

BMC Gastroenterol. 2012 Mar 27;12:27. doi: 10.1186/1471-230X-12-27.

10.

HIV infection does not affect the performance of noninvasive markers of fibrosis for the diagnosis of hepatitis C virus-related liver disease.

Nunes D, Fleming C, Offner G, O'Brien M, Tumilty S, Fix O, Heeren T, Koziel M, Graham C, Craven DE, Stuver S, Horsburgh CR Jr.

J Acquir Immune Defic Syndr. 2005 Dec 15;40(5):538-44.

PMID:
16284529
11.

[Retrospective study of FibroScan, APRI, FIB-4 and FORNS indexes compared with liver biopsy in the evaluation of liver fibrosis in patients with chronic hepatitis C monoinfection and HIV coinfection].

González Guilabert MI, Hinojosa Mena-Bernal C, del Pozo González J, del Pozo Pérez MA.

Gastroenterol Hepatol. 2010 Jun-Jul;33(6):425-32. doi: 10.1016/j.gastrohep.2010.02.005. Epub 2010 May 14. Spanish.

PMID:
20471720
12.

Non-invasive fibrosis biomarkers - APRI and Forns - are associated with liver stiffness in HIV-monoinfected patients receiving antiretroviral drugs.

Hasson H, Merli M, Galli L, Gallotta G, Carbone A, Messina E, Bagaglio S, Morsica G, Salpietro S, Castagna A, Lazzarin A, Uberti-Foppa C.

Liver Int. 2013 Aug;33(7):1113-20. doi: 10.1111/liv.12159. Epub 2013 Mar 28.

PMID:
23534616
13.

Liver fibrosis on account of chronic hepatitis C is more severe in HIV-positive than HIV-negative patients despite antiretroviral therapy.

de Lédinghen V, Barreiro P, Foucher J, Labarga P, Castéra L, Vispo ME, Bernard PH, Martin-Carbonero L, Neau D, García-Gascó P, Merrouche W, Soriano V.

J Viral Hepat. 2008 Jun;15(6):427-33. doi: 10.1111/j.1365-2893.2007.00962.x. Epub 2008 Jan 22.

PMID:
18221303
14.

Noninvasive serum fibrosis markers for screening and staging chronic hepatitis C virus patients in a large US cohort.

Holmberg SD, Lu M, Rupp LB, Lamerato LE, Moorman AC, Vijayadeva V, Boscarino JA, Henkle EM, Gordon SC; Chronic Hepatitis Cohort Study (CHeCS) Investigators.

Clin Infect Dis. 2013 Jul;57(2):240-6. doi: 10.1093/cid/cit245. Epub 2013 Apr 16.

15.

Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.

Toniutto P, Fabris C, Bitetto D, Falleti E, Avellini C, Rossi E, Smirne C, Minisini R, Pirisi M.

J Gastroenterol Hepatol. 2007 Nov;22(11):1904-8.

PMID:
17914968
16.

Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohort.

Loko MA, Castera L, Dabis F, Le Bail B, Winnock M, Coureau G, Bioulac-Sage P, de Ledinghen V, Neau D; Groupe d'Epidémiologie Clinique du SIDA en Aquitaine (GECSA).

Am J Gastroenterol. 2008 Aug;103(8):1973-80. doi: 10.1111/j.1572-0241.2008.01954.x.

PMID:
18796094
17.

Validation and comparison of simple noninvasive models for the prediction of liver fibrosis in chronic hepatitis C.

Amorim TG, Staub GJ, Lazzarotto C, Silva AP, Manes J, Ferronato Mda G, Shiozawa MB, Narciso-Schiavon JL, Dantas-Correa EB, Schiavon Lde L.

Ann Hepatol. 2012 Nov-Dec;11(6):855-61.

PMID:
23109448
18.

[Evaluation of APRI score in liver disease following the introduction of antiretroviral therapy in HIV and HCV coinfected versus HIV monoinfected patients].

Antonello VS, Tovo CV, Kliemann DA, Santos BR, Zaltron VF.

Rev Soc Bras Med Trop. 2010 Nov-Dec;43(6):678-81. Portuguese.

19.

[Grade of consistency existing in the grade of hepatic fibrosis calculated with the APRI and FORNS biochemistry indexes and transient elastography (Fibroscan in patients coinfected with HIV-HCV].

Ibáñez JG, Pérez M, Lamas JL, Ocampo A, Vázquez CM, Ribera A.

Rev Clin Esp. 2010 Jul-Aug;210(7):317-22. doi: 10.1016/j.rce.2010.02.006. Epub 2010 May 12. Spanish.

PMID:
20466359
20.

Assessing mortality in women with hepatitis C virus and HIV using indirect markers of fibrosis.

Bambha K, Pierce C, Cox C, French AL, Tien PC, Sharp GB, Augenbraun M, Glesby MJ, Villacres MC, Plankey M, Strickler HD, Gange SJ, Peters MG.

AIDS. 2012 Mar 13;26(5):599-607. doi: 10.1097/QAD.0b013e32834fa121.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk